Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) reported a net profit attributable to shareholders of 105.6 million yuan for the quarter ended Sept. 30, a 13.13% decrease from the prior-year period, according to a Friday filing with the Hong Kong bourse.
Earnings per share were 0.45 yuan, an 11.76% drop from a year ago.
The revenue for the quarter was 670.4 million yuan, 0.22% more than the previous year's quarter.
The company's shares were down by almost 11% in recent trading.
Price (HKD): $30.25, Change: $-3.7, Percent Change: -10.77%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.